Full macular translocation for choroidal neovascularization in the era of intravitreal pharmacological therapy

Retina

Volumn 30, Issue 10, 2010, Pages 1739-1743

  Haverbeke, Greg M ^a   Claes, Carl ^a  

^a Division of Vitreoretinal   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BEVACIZUMAB; TRIAMCINOLONE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; EYE SURGERY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; RETINA SURGERY; SUBRETINAL NEOVASCULARIZATION; SURGICAL APPROACH; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY;

EID: 78649355221     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181f57d3d     Document Type: Article

References (36)

1. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Langnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007;114:253-262.
2. Björnsson OM, Syrdalen P, Bird AC, Peto T, Kinge B. The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study. Acta Oph-thalmol Scand 2006;84:636-641.
3. Treatment of Age-Related Macular Degeneration with Photo-dynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment\TAP and VIP report no. 2. Arch Ophthalmol 2003;121:1253-1268.
4. Treatment of Age-Related Macular Degeneration with Photo-dynamic Therapy Study Group; Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol 2003;136:407-418.
5. Schmidt-Erfurth UM, Richard G, Augustin A, et al. On behalf of the European Society for Retina Specialists' Guidelines Committee (EURETINA). Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthal-mol Scand 2007;85:486-494. (Pubitemid 47163109)
6. Emerson MV, Lauer AK, Flaxel CJ, et al. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 2007;27:439-444.
7. Chakravarthy U, Soubrane G, Bandello F, et al. Evolving European guidance on the medical management of neovascular age related macular degeneration. Br J Ophthalmol 2006;90: 1188-1196.
8. Atmani K, Coscas F, Coscas G, et al. Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series. Eye 2009;23: 1150-1154.
9. Lux A, Llacer H, Heussen FM, Janisen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol 2007;91:1318-1322.
10. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007;144:627-637.
11. Machemer R. Macular translocation. Am J Ophthalmol 1998; 125:698-700.
12. Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina 2001;21:293-303.
13. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 2003;87:615-621.
14. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 2002;134:560-565.
15. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999;237:313-325.
16. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular trans-location with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2002;120:451-459. (Pubitemid 34727816)
17. Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology 2004;111:1715-1724.
18. de Juan E Jr, Loewenstein A, Bressler NM, Alexander J. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. Am J Ophthalmol 1998:125:635-646. (Pubitemid 28265512)
19. Nishimura A, Kobayashi A, Segawa Y, et al. Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 2003;23:777-779.
20. Rosenfeld PJ, Brown DM, Heier JS. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
21. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
22. Takeda AL, Colquitt J, Clegg AJ, Jones J. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Br J Ophthalmol 2007;91: 1177-1182.
23. Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 2006;19: 361-372.
24. Rosenfeld PJ, Heier JS, Hantsbarger G, Shanj N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006;113:632.
25. Kaiser PK, Blodi BA, Shapiro H, Achargor NR; MARINA Study Group. Angiographic and optical coherence tomo-graphic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-1875.
26. Kourlas H, Abrams P. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review. Clin Ther 2007;29:1850-1861.
27. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Adrarga NR. MARINA Study Group. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:246-252.
28. Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2007;27:535-540.
29. Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neo-vascular age-related macular degeneration. Retina 2006;26: 495-511.
30. Tezel TH, Kaplan HJ. Are intravitreal anti-VEGF antibodies safe? Ocul Immunol Inflamm 2007;15:1-2.
31. Shima C, Sakaguchi H, Gomi F, et al. Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 2008;86:372-376.
32. Olsen TW. Treatment of exudative age-related macular degeneration: many factors to consider. Am J Ophthalmol 2007;144:281-283.
33. Frennesson C. Promising treatment of neovascular age-related macular degeneration is coming. But to what price? Lakartid-ningen 2007;104:486-487.
34. Luke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F. Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration\a report of 1 year results. Graefes Arch Clin Exp Ophthalmol 2007;245: 1831-1836. (Pubitemid 350154018)
35. Gelisken F, Voelker M, Schwabe R, et al. Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol 2007; 245:1085-1095. (Pubitemid 47034332)
36. Bressler NM, Bressler SB, Hawkins BS, et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: ophthlamic outcomes submacular surgery trials pilot study report number 1. Am J Ophthalmol 2000;130:387-407.